Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

Author： Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.17, 2001-01, pp. : 2194-2198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)

By Boni C.   Savoldi L.   Bisagni G.   Ceci G.   Crino L.   De Lisi V.   Di Costanzo F.   Lasagni L.   Manenti A.L.   Moretti G.   Rondini E.   Sassi M.   Zadro A.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1974-1976

Elsevier

Access to resources Recommend Favorite

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases - a phase II study of the EORTC Lung Cancer Group (08965)

By Dziadziuszko R.   Ardizzoni A.   Postmus P.E.   Smit E.F.   Price A.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1271-1276

Elsevier

Access to resources Recommend Favorite

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

By Nogami Naoyuki   Hotta Katsuyuki   Segawa Yoshihiko   Takigawa Nagio   Hosokawa Shinobu   Oze Isao   Fujii Masanori   Ichihara Eiki   Shibayama Takuo   Tada Atsuhiko   Hamada Noboru   Uno Masatoshi   Tamaoki Akihiko   Kuyama Shoichi   Ikeda Genyo   Osawa Masahiro   Takata Saburo   Tabata Masahiro   Tanimoto Mitsune   Kiura Katsuyuki  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 768-773

Informa Healthcare

Access to resources Recommend Favorite

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

By Casal Rubio J.   Fírvida-Pérez J.   Lázaro-Quintela M.   Barón-Duarte F.   Alonso-Jáudenes G.   Santomé L.   Afonso-Afonso F.   Amenedo M.   Huidobro G.   Campos-Balea B.   López-Vázquez M.   Vázquez S.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 451-457

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

By Kontopodis Emmanouil  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 49-55

Maney Publishing

Access to resources Recommend Favorite